FI922325A0 - Oral sammansaettning foer botning av inflammatoriska tarmkanalsjukdomar. - Google Patents

Oral sammansaettning foer botning av inflammatoriska tarmkanalsjukdomar.

Info

Publication number
FI922325A0
FI922325A0 FI922325A FI922325A FI922325A0 FI 922325 A0 FI922325 A0 FI 922325A0 FI 922325 A FI922325 A FI 922325A FI 922325 A FI922325 A FI 922325A FI 922325 A0 FI922325 A0 FI 922325A0
Authority
FI
Finland
Prior art keywords
oral
tarmkanalsjukdomar
inflammatoriska
botning
sammansaettning
Prior art date
Application number
FI922325A
Other languages
English (en)
Other versions
FI922325A (fi
FI104949B (fi
Inventor
Jan Ulimus
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20377544&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI922325(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Draco Ab filed Critical Draco Ab
Publication of FI922325A publication Critical patent/FI922325A/fi
Publication of FI922325A0 publication Critical patent/FI922325A0/fi
Application granted granted Critical
Publication of FI104949B publication Critical patent/FI104949B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
FI922325A 1989-11-22 1992-05-21 Menetelmä säädellysti budesonidia vapauttavan oraalisesti annettavan koostumuksen valmistamiseksi FI104949B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE8903914A SE8903914D0 (sv) 1989-11-22 1989-11-22 Oral composition for the treatment of inflammatory bowel diseases
SE8903914 1989-11-22
SE9000738 1990-11-15
PCT/SE1990/000738 WO1991007172A1 (en) 1989-11-22 1990-11-15 Oral composition for the treatment of inflammatory bowel diseases

Publications (3)

Publication Number Publication Date
FI922325A FI922325A (fi) 1992-05-21
FI922325A0 true FI922325A0 (fi) 1992-05-21
FI104949B FI104949B (fi) 2000-05-15

Family

ID=20377544

Family Applications (2)

Application Number Title Priority Date Filing Date
FI922325A FI104949B (fi) 1989-11-22 1992-05-21 Menetelmä säädellysti budesonidia vapauttavan oraalisesti annettavan koostumuksen valmistamiseksi
FI991893A FI19991893A (fi) 1989-11-22 1999-09-06 Säädellysti budesonidia vapauttava oraalisesti annettava koostumus ja budesonidin käyttö

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI991893A FI19991893A (fi) 1989-11-22 1999-09-06 Säädellysti budesonidia vapauttava oraalisesti annettava koostumus ja budesonidin käyttö

Country Status (36)

Country Link
US (1) US6423340B1 (fi)
EP (1) EP0502092B1 (fi)
JP (1) JP3145111B2 (fi)
KR (1) KR0179042B1 (fi)
AT (1) ATE125445T1 (fi)
AU (1) AU643021B2 (fi)
CA (1) CA2071518C (fi)
DE (1) DE69021214T2 (fi)
DK (1) DK0502092T3 (fi)
EG (1) EG19642A (fi)
ES (1) ES2074698T3 (fi)
FI (2) FI104949B (fi)
GR (1) GR3017691T3 (fi)
HK (1) HK51897A (fi)
HR (1) HRP920632B1 (fi)
HU (2) HUT60630A (fi)
IE (1) IE74854B1 (fi)
IL (1) IL96415A (fi)
IS (1) IS1858B (fi)
LT (1) LT3696B (fi)
LV (1) LV10183B (fi)
MY (1) MY104535A (fi)
NO (1) NO304010B1 (fi)
NZ (1) NZ235807A (fi)
PL (1) PL166506B1 (fi)
PT (1) PT95946A (fi)
RU (1) RU2134104C1 (fi)
SA (1) SA90110123B1 (fi)
SE (1) SE8903914D0 (fi)
SG (1) SG54210A1 (fi)
SI (1) SI9012150A (fi)
TW (1) TW250435B (fi)
UA (1) UA37196C2 (fi)
WO (1) WO1991007172A1 (fi)
YU (1) YU48583B (fi)
ZA (1) ZA908777B (fi)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5316772A (en) * 1990-12-19 1994-05-31 Solvay & Cie, S.A. (Societe Anonyme) Bilayered oral pharmaceutical composition with pH dependent release
SK87295A3 (en) * 1993-01-08 1996-04-03 Astra Ab Novel colon or ileum-specific steroid derivatives
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
DE4332394A1 (de) * 1993-09-23 1995-03-30 Falk Pharma Gmbh Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
KR20000053327A (ko) * 1996-11-15 2000-08-25 데이비드 엠 모이어 결장내 운반에 사용되는 약학적 제형
SE9604751D0 (sv) 1996-12-20 1996-12-20 Astra Ab New therapy
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US6239120B1 (en) 1998-03-17 2001-05-29 Pharmalink Ab Method and means for treating glomerulonephritis
GB9824604D0 (en) 1998-11-11 1999-01-06 Hewlett Healthcare Limited Treatment of allergic conditions
SE9902673D0 (sv) * 1999-07-12 1999-07-12 Astra Ab New composition
NZ528607A (en) * 2001-03-15 2007-11-30 Enteron Pharmaceuticals Inc Method of treating inflammatory GI disorders using topically active corticosteroids to reduce symptoms without causing the side effects associated with systemic steroid administration
DE10250543A1 (de) * 2002-10-29 2004-05-19 Röhm GmbH & Co. KG Mehrschichtige Arzneiform
AU2003293833B2 (en) 2002-12-12 2009-10-01 Covis Pharma B.V. Combination medicament
US20060188563A1 (en) * 2003-03-27 2006-08-24 Hisamitsu Pharmaceutical Co., Inc. Medicinal oral preparations for colon delivery, medicinal oral preparations for treating colon cancer and medicinal oral preparations for treating colitis
DE602004028497D1 (de) * 2003-09-15 2010-09-16 Nycomed Gmbh Verwendung von ciclesonid zur behandlung von entzündlichen darmerkrankungen
JP5618452B2 (ja) 2003-09-16 2014-11-05 タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツングＴａｋｅｄａ ＧｍｂＨ 呼吸器疾患の治療のためのシクレソニドの使用
WO2006009602A2 (en) 2004-06-16 2006-01-26 Tap Pharmaceutical Products, Inc. Multiple ppi dosage form
WO2007056539A2 (en) * 2005-11-08 2007-05-18 Medarex, Inc. Prophylaxis and treatment of enterocolitis associated with anti-ctla-4 antibody therapy
EP2143424A4 (en) * 2007-03-26 2013-07-31 Teikoku Seiyaku Kk ORAL PHARMACEUTICAL PREPARATION FOR SPECIFIC DELIVERY TO THE COLON
GB0808537D0 (en) 2008-05-12 2008-06-18 Archimedes Dev Ltd Compositions
MX2011003595A (es) * 2008-10-03 2011-07-28 Falk Pharma Gmbh Composiciones y metodos para el tratamiento de enfermedades intestinales con mesalamina granulada.
US8945616B2 (en) 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
US8945615B2 (en) 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
MX2013009033A (es) * 2011-02-04 2013-09-06 Optimer Pharmaceuticals Inc Tratamiento de infecciones bacterianas.
MD480Z (en) * 2011-07-07 2012-09-30 Elvira Andon Method for treating acute ulcerative nonspecific colitis
SI2659881T1 (en) 2012-04-30 2018-03-30 Tillotts Pharma Ag Formulation of the delayed release medicinal product
MY189394A (en) 2013-10-29 2022-02-09 Tillotts Pharma Ag A delayed release drug formulation
WO2017042835A1 (en) * 2015-09-11 2017-03-16 Sun Pharmaceutical Industries Ltd. Oral pharmaceutical dosage forms of budesonide
CN105663091A (zh) * 2016-01-28 2016-06-15 上海信谊百路达药业有限公司 一种布地奈德肠溶缓释胶囊及其制备方法
CA3011565C (en) * 2016-02-09 2024-01-02 Albireo Ab Oral cholestyramine formulation and use thereof
ES2874546T3 (es) * 2016-02-09 2021-11-05 Albireo Ab Formulación oral de colestiramina y uso de la misma
EP3613414A1 (de) 2018-08-24 2020-02-26 Dr. Falk Pharma Gmbh Pellets mit mehrschichtiger struktur zur verzögerten freisetzung des wirkstoffs im distalen kolon
US11896719B2 (en) 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996356A (en) 1969-07-02 1976-12-07 Hoffmann-La Roche Inc. Composition containing 5-sulfanilamido-3,4-dimethylisoxazole and a trimethoxybenzyl pyrimidine
SE378109B (fi) 1972-05-19 1975-08-18 Bofors Ab
SE7813246L (sv) 1978-12-22 1980-06-23 Haessle Ab Fast farmaceutisk beredning innehallande kroppar med flera ytskikt
FR2471186A1 (fr) 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
SE8003805L (sv) 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
SE8008524L (sv) 1980-12-04 1982-06-05 Draco Ab 4-pregnen-derivat, ett forfarande for deras framstellning, beredning och metod for behandling av inflammatoriska tillstand
ZA825384B (en) 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
SE8306370D0 (sv) 1983-11-18 1983-11-18 Draco Ab Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions
US4708867A (en) 1983-12-19 1987-11-24 Key Pharmaceuticals, Inc. Minipellets
US4606940A (en) 1984-12-21 1986-08-19 The Ohio State University Research Foundation Small particle formation and encapsulation
DE3536267A1 (de) 1985-10-11 1987-04-16 Bayer Ag Azofarbstoffe sowie fluessigkristallines material enthaltend azofarbstoffe
SE8506015D0 (sv) 1985-12-19 1985-12-19 Draco Ab Novel 16,17-acetalsubstituted pregnane 21-oic acid derivatives
GB8630913D0 (en) * 1986-12-24 1987-02-04 Glaxo Group Ltd Pharmaceutical compositions
US4966770A (en) 1989-07-26 1990-10-30 Himedics, Inc. Prednisone microencapsulated granules
DE10307386A1 (de) 2003-02-21 2004-09-09 Dieter Wildfang Gmbh Verfahren zum außenseitigen Beschichten eines sanitären Auslaufteiles sowie sanitäres Auslaufteil

Also Published As

Publication number Publication date
RU2134104C1 (ru) 1999-08-10
SE8903914D0 (sv) 1989-11-22
FI19991893A (fi) 1999-09-06
FI922325A (fi) 1992-05-21
EP0502092B1 (en) 1995-07-26
LT3696B (en) 1996-02-26
IE904170A1 (en) 1991-05-22
PL287844A1 (en) 1991-12-02
WO1991007172A1 (en) 1991-05-30
SG54210A1 (en) 1998-11-16
NZ235807A (en) 1993-02-25
EG19642A (en) 1995-08-30
EP0502092A1 (en) 1992-09-09
ES2074698T3 (es) 1995-09-16
IL96415A0 (en) 1991-08-16
HK51897A (en) 1997-05-02
JP3145111B2 (ja) 2001-03-12
US6423340B1 (en) 2002-07-23
CA2071518C (en) 2002-11-12
ATE125445T1 (de) 1995-08-15
SI9012150A (sl) 1998-08-31
IL96415A (en) 1995-11-27
NO922004L (no) 1992-05-21
JPH05501705A (ja) 1993-04-02
NO922004D0 (no) 1992-05-21
YU48583B (sh) 1998-12-23
IS3644A7 (is) 1991-05-23
IE74854B1 (en) 1997-08-13
DE69021214D1 (de) 1995-08-31
AU643021B2 (en) 1993-11-04
UA37196C2 (uk) 2001-05-15
KR920703025A (ko) 1992-12-17
LV10183A (lv) 1994-10-20
GR3017691T3 (en) 1996-01-31
SA90110123B1 (ar) 1999-06-06
HRP920632A2 (en) 1995-04-30
LTIP1751A (en) 1995-07-25
HRP920632B1 (en) 1999-10-31
NO304010B1 (no) 1998-10-12
PT95946A (pt) 1991-09-13
PL166506B1 (pl) 1995-05-31
DE69021214T2 (de) 1996-01-04
YU215090A (sr) 1996-01-09
DK0502092T3 (da) 1995-12-27
CA2071518A1 (en) 1991-05-23
KR0179042B1 (ko) 1999-03-20
IS1858B (is) 2003-03-27
HUT60630A (en) 1992-10-28
FI104949B (fi) 2000-05-15
HU216836B (hu) 1999-09-28
TW250435B (fi) 1995-07-01
MY104535A (en) 1994-04-30
HU9201700D0 (en) 1992-08-28
AU7786491A (en) 1991-06-13
LV10183B (en) 1995-08-20
ZA908777B (en) 1991-07-31

Similar Documents

Publication Publication Date Title
FI922325A (fi) Oral sammansaettning foer botning av inflammatoriska tarmkanalsjukdomar.
LV10878A (lv) Adas apstradasana ar izveletiem amfifiliem kopolimeriem
EP0151989A3 (en) Means for the treatment of cardiac diseases
NO894222L (no) Fremgangsmaater for behandling og profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer for anvendelse i nevnte metoder.
MD990258A (en) Method of treatment of the acute viral hepatitis B
NO960545D0 (no) Behandling av skadelige virkninger i forbindelse med administrering av ekstracellulært hemoglobin
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
KR900017599A (ko) 종양 치료용 약학 조성물
NO172538C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 6-fenoksymetyl-4-hydroksytetrahydropyran-2-oner og 6-tiofen-oksymetyl-4-hydroksytetrahydropyran-2-oner
ATE178800T1 (de) Pharmazeutische pentapeptid-zusammensetzung und ihre verwendung
ATE59776T1 (de) Pharmazeutische zusammensetzung und behandlung.
NO920031D0 (no) Synergistisk middel for terapeutisk behandling, preparat inneholdende nevnte middel, og anvendelse av middelet for fremstilling av et legemiddelpreparat
RU95108375A (ru) Способ профилактики и лечения коронарогенных повреждений миокарда
RU99107944A (ru) Лечебное средство прямого антикоагулянтного и фибринолитического действия
RU94037731A (ru) Способ лечения рассеянного склероза
NO880841D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.